Monday, March 20, 2017 1:11:37 PM
It's important to recognize that Otiko has not developed a single product that he markets today. He has NON-EXCLUSIVE licenses to manufacture Viabecline at Dr. Phillips' facility in Oklahoma and distribute it. He uses his own business Coast to Coast Podiatry business to distribute this product.
Here is an excerpt from a previous exchange between the two transdermal patent owners and a shareholder. It's linked in the iBox if you need to reference it again.
Dr. Phillips Response:
Q: [Can you] enlighten me regarding the licensing of some of the drug products you market. Specifically Diabecline and Tetrastem.
Quote:We have not licensed TetraStem.
We have non-exclusive licenses with two companies for Diabecline.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129232062
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM